0001209191-22-035690.txt : 20220609 0001209191-22-035690.hdr.sgml : 20220609 20220609212233 ACCESSION NUMBER: 0001209191-22-035690 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220607 FILED AS OF DATE: 20220609 DATE AS OF CHANGE: 20220609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shanafelt Armen CENTRAL INDEX KEY: 0001656151 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37722 FILM NUMBER: 221007460 MAIL ADDRESS: STREET 1: C/O LILLY VENTURES FUND I, LLC STREET 2: 115 W. WASHINGTON STREET,STE 1680-SOUTH CITY: INDIANAPOLIS STATE: IN ZIP: 46204 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aeglea BioTherapeutics, Inc. CENTRAL INDEX KEY: 0001636282 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464312787 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 805 LAS CIMAS PARKWAY STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: (512) 942-2935 MAIL ADDRESS: STREET 1: 805 LAS CIMAS PARKWAY STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78746 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-07 0 0001636282 Aeglea BioTherapeutics, Inc. AGLE 0001656151 Shanafelt Armen C/O AEGLEA BIOTHERAPEUTICS, INC. 805 LAS CIMAS PARKWAY, SUITE 100 AUSTIN TX 78746 1 0 0 0 Director Stock Option (right to buy) 0.73 2022-06-07 4 A 0 43000 0.00 A 2032-06-06 Common Stock 43000 43000 D The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 7, 2022, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date. /s/ James Kastenmayer, by power of attorney 2022-06-09